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Abstract 
 
The effect of methanolic extract of Hymenocardia acida leaves on diabetes and associated lipidemia were investigated 
on experimentally-induced diabetic rats. The extract did not demonstrate any acutely toxic effect in rats within the dose range 
(250 mg/kg - 2000 mg/kg) employed in the study; hence it was well tolerated by the rats. In all experiments, the anti-diabetic 
effects were dose-dependent and comparable to that of glibenclamide (2 mg/kg) standard. At a dose of 500 mg/kg, lipid profile 
markers such as the serum total cholesterol (TC) levels, LDL-C, triglycerides and HDL-C were significantly lower (p <0.05) than 
those of both the treated and untreated controls.  
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Introduction 
 
Diabetes mellitus (DM) is a multi-factorial disease characterised by hyperglycaemia and lipoprotein abnormalities 
(Scoppola et al., 2001). The disease affects approximately more than 5% of the world’s population (Kameswararao et al., 2003). 
Apart from the hyperglycaemia, several factors including dyslipidemia or hyperlipidemia are involved in the micro- and 
macrovascular complications associated with the disease; a major cause of morbidity and death (Taskinen, 1993). Diabetic disease 
is increasing rapidly and vast amounts of resources are spent in all countries (Verspohl, 2002). Currently available therapies for 
diabetes include insulin and various oral anti-diabetic agents such as sulfonylureas, biguanides, alpha-glucosidase inhibitors, 
troglitazones, etc; used either as monotherapy or in combination to achieve better glycaemic conditions. Each of the above oral 
agents suffers from various serious adverse effects.  Furthermore, the overall search for anti-diabetic agents has not been rewarded 
with marketable novel agents in the last two decades (Dewanjee et al., 2008); attempts are still made to find such drugs.  
Plants however have played a significant role in the introduction of new therapeutic agents. Metformin was discovered 
from Galega officinalis, a medicinal plant. In Nigeria, traditional medicine occupies a unique position in health care delivery, 
especially among the rural populace. However, the activities of herbalists are surrounded with a lot of secrecy and lack of 
scientific procedure, hence the need to standardise the practice of traditional medicine.  
Folkloric uses of  the leaves of Hymenocardia acida include the treatment of conditions like diarrhoea (Tona et al., 
1999), malaria (Vonthron-Sénécheau et al., 2003), dysentery, diabetes mellitus by the Igede people of Benue State (Igoli et al., 
2005), Wounds and Skin diseases (Igoli et al., 2003) and is also shown to have anti-tumour and anti-HIV activities (Muanza et al., 
1995). The present investigation was therefore intended to examine the potential anti-diabetic activity of the methanolic leaf 
extracts of H. acida using alloxan induced-diabetic rat model.  
 
 
Materials and Methods  
 Animals  
 
Out bred Albino Wistar rats of both sexes weighing 185 - 278 g were purchased from the Laboratory Animal Facility of 
the Department of Veterinary Physiology and Pharmacology, University of Nigeria, Nsukka and used. They were kept in clean 
stainless steel wire mesh cages, maintained at normal temperature and natural daylight/night conditions. They were allowed free 
access to standard commercial pelleted feed and clean drinking water. Ethical conditions as stipulated by Ward and Elsea (1997) 
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Absorbance of Test sample 
Absorbance of standard 
Abs of Unknown 
Abs of standard 
in the conducts of experiments with life animals were adhered to strictly. The study protocol was approved by the Faculty of 
Veterinary Medicine’s ethical committee. 
  
Plant material 
 
Fresh leaves of Hymenocardia acida (HA) were collected in the month of March 2009, from Nsukka metropolis, Enugu 
state, Nigeria. The leaves were identified as Hymenocardia acida belonging to the family Hymenocardiaceae by Mr. A.O. 
Ozioko, a taxonomist with the International Centre for Ethnomedicine and Drug Development, Nsukka. Voucher specimen 
(UNVPP/2009/3001/11) was kept in the herbarium of the Department of Veterinary Physiology and Pharmacology for reference. 
The Fresh leaves were washed clean with water and dried under mild sunlight. The dried plants were pulverized into coarse 
powder and 500 g of the powder were extracted in 80% methanol for 48 hrs with intermittent shaking. Thereafter, filtration was 
done using filter papers and funnel into an already weighed beaker. The solvent was allowed to evaporate in an electric oven at 
40oC. 
 
 Acute toxicity test 
 
Five groups of six rats each were used. They were treated orally with varying doses (250 mg/kg, 500 mg/kg, 1000mg/kg 
and 2000 mg/kg) of HA extract dissolved in water. The rats were allowed free access to feed and water ad libitum and were 
observed over a period of 24 h for signs of acute toxicity and death. LD50 was determined using the method of Miller and Tainter 
(1937). 
  
Hypoglycaemic effect in alloxan-diabetic rats 
 
Hyperglycaemia was induced by the methods of Vinuthan, et al., (2007). A single intraperitoneal administration of 150 
mg/kg of freshly prepared alloxan monohydrate in distilled water to overnight fasted rats and observed for hyperglycaemia after 
13 days. Thirty diabetic rats of both sexes were randomly divided into five groups containing six animals each and treated thus; 
the positive control received Glibenclamide (2 mg/kg, p.o.) dissolved in distilled water, while the negative control received equal 
volume of distilled water orally. The test groups were given varying doses- 250 mg/kg, 500 mg/kg and 1000 mg/kg of the 
methanolic HA extract, orally. Blood samples were collected at 0, 30, 60 and 120 mins post-treatment by a tail tip-snip cut. The 
plasma glucose concentration of the rats was determined with the aid of an electronic glucose meter (Accu- Chek Advantage) and 
glucose strips (Accu-Chek Advantage II). The mean anti-diabetic response observed was recorded as mmol/L and used to 
determine the dose-response effect of H. acida. The results obtained were subjected to one-way ANOVA. 
 
Sub-acute anti-diabetes study  
 
Thirty (30) rats of both sexes were made diabetic using the methods described by Vinuthan et al. (2007) and randomly 
divided into three (3) groups of ten (10) rats each and employed in the study. Group A received Glibenclamide (2 mg/kg) and 
served as positive control. Group B received 500 mg/kg of the methanolic plant extract of H. acida and Group C received equal 
volume of distilled water (negative control) every day for seventeen (17) days. The blood glucose levels were determined on day 
0, 5, 11 and 17 being the last day of the experiment. On the last day all animals were bled from the orbital sinus under mild ether 
anaesthesia to obtain larger quantity of blood, which was clotted in test-tubes and the sera obtained was used for biochemical 
assay to determine the lipid profile. 
 
Biochemical estimations 
 
Serum Total Cholesterol (TC) was evaluated using commercial assay kits following the methods described by Allain et 
al., (1974). The experiment was done in triplicates. Mean values were obtained and used for the following calculation: 
 
                                                           X 200 = TC value of test sample (mg/dl) 
 
Low Density Lipoproteins (LDL-C) was determined as the difference between total cholesterol and cholesterol content of the 
supernatant after precipitation of the LDL fraction by Polyvinyl sulphate (PVS) in the presence of Polyethylene-glycol 
monomethyl ether (Bergmenyer, 1985). The experiment was done in triplicate for each sample and the mean was used for the 
following calculation: 
LDL-Cholesterol (mg/dl) = TC (mg/dl) – 1.5 X Supernatant cholesterol (mg/dl). 
Serum Triglycerides (STG) was estimated by adopting the method of Footsati and Principe (1982).  Absorbances of all the tubes 
were taken spectrophotometrically at 520 nm wavelength. The results were obtained in triplicates. The mean of which was used  
for the following calculation: 
 
                                                                            X Concentration of standard (mg/dl) = STG Value of unknown (mg/dl) 
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High Density Lipoproteins (HDL-C) in serum were also calculated as per Friedewald’s equation (Friedewald et al., 1972).  The 
Friedewald’s equation estimates the value of HDL-C using the values of other cholesterol such as LDL-C.  
HDL-C = TC – LDL-C – kSTG 
Where HDL-C is High density lipoprotein 
LDL-C is Low density lipoproteins 
STG is Serum triglycerides 
Constant value, k was 0.20, measurements were taken in mg/dl.  
 
Data analysis 
 
Data obtained were presented as mean ± SEM and analysed using one-way analysis of variance (ANOVA) and post-hoc 
comparisons were carried out using Dunnet's t-test. Values of P<0.05 were considered significant in the study. 
 
 
Results 
Plant Extraction 
 
The 80% methanol extract of HA leaves was dark brown in colour. The yield of the extract was 27.49 g (5.5% w/w). 
 
Acute toxicity 
 
No deaths were recorded after 24 hrs of administration of the various doses (250 mg/kg, 500 mg/kg, 1000 mg/kg and 
2000 mg/kg) of the methanolic extract of H. acida. All the rats treated with the extract were dull; clustered together for about 
seven hours following the oral administration of the extract. The rats recovered 9 hours post administration and became very 
active.  
 
Hypoglycaemic effect 
 
All doses (250, 500 and 1000 mg/kg) of the extract and glibenclamide (2mg/kg) when compared to the untreated 
control, significantly reduced the fasting blood glucose levels of alloxan diabetic rats. There was a significant rise in the mean 
fasting blood glucose level of the rats treated with 250 mg/kg of the test extract, 6 hrs post treatment compared with untreated 
control (Figure 1). The 500 mg/kg dose showed a time-dependent anti-diabetic activity throughout the duration of the experiment, 
hence it was the preferred dose for the sub-acute anti-diabetes study. 
 
 
 
 
Figure 1:  Time-response effect of various doses of the methanolic leaf extract of H. acida 
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Figure 2: The effect of the oral administration of the methanol extract of H. acida on serum total cholesterol, triglycerides, low 
density lipoproteins and high density lipoproteins 
 
Biochemical assay 
 
Figure 2 shows the effect of the oral administration of the methanol extract of H. acida on serum total cholesterol, 
triglycerides, low density lipoproteins and high density lipoproteins. The rats treated with glibenclamide showed a marked 
increase in total cholesterol, triglycerides, high density lipoprotein and a fall in low density lipoprotein. Treatment with HA 
extracts (500 mg/kg) daily for 17 days (Table 1), significantly (P <0.05) lowered the serum total cholesterol, LDL-C, triglycerides 
and HDL-C levels compared to those of both the treated and untreated controls. 
 
 
Table 1: Mean blood glucose levels during a 17-day sub-chronic anti-diabetes study of the leaf extracts of H. acida in alloxan 
induced diabetic rats. 
Test Extract 
500 mg/kg 
0 Hrs 3 Hrs 6 Hrs 12 Hrs 
DAY 0 15.37±3.72 - - 26.65±3.86 
DAY 5 19.47±6.54b 17.46±5.75 15.70±5.42 9.73±4.08 
DAY 11 11.79±5.06 14.77±6.56a 11.48±4.63 8.76±4.03 
DAY 17 8.86±2.99 9.28±2.70 10.47±5.98a 8.52±4.02 
Glibenclamide  
2 mg/kg 
    
DAY 0 21.06±6.17 - - 25.26±6.32 
DAY 5 24.09±8.69 20.14±5.16 22.34±3.67 17.66±3.44 
DAY 11 19.31±6.47 19.50±6.10 17.60±5.46 15.01±5.66 
DAY 17 16.06±8.65 13.86±7.70 15.29±11.22 9.99±8.38 
Distilled Water     
DAY 0 18.21±6.53 - - 22.63±5.63 
DAY 5 29.73±5.04 26.24±5.66 27.14±7.12 26.59±4.49 
DAY 11 17.36±4.18 19.51±6.10 20.50±6.23 25.86±4.79 
DAY 17 21.94±6.58 23.55±5.42 25.41±6.58 25.70±5.66 
 
a values are significantly different from positive control, glibenclamide (P <0.01).  
b values are significantly different from negative control, distilled water (P <0.05). 
Values are postprandial blood glucose levels in each group expressed as mean ± S.E.M. 
 
 
 
Discussion 
 
The methanol extract of the leaves of H. acida gave a yield of 5.5% w/w dry matter and did not produce death at doses 
used in the study. No death was recorded even at a high dose of 2000 mg/kg, which is an indication that the extract was well 
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tolerated by the rats. However, the rats showed signs of dullness which indicates that the extract may have depressive effects on 
the central nervous system.  
Experimental rats were considered diabetic when the blood glucose levels of alloxan induced diabetic rats were 16.4 
mmol/dl and above (Vinuthan et al., 2007). The extract of H. acida did not indicate a dose-dependent effect being that the 
response with the highest dose of 1000mg/kg did not produce better hypoglycaemic activity as expected. This is suspected to be 
as a result of the saturation of receptors. The extract however showed a consistent time-dependent decrease in the fasting blood 
glucose levels of test rats at a dose of 500 mg/kg over a six-hr study period as against the 250 mg/kg and 1000 mg/kg doses; and 
was therefore the preferred dose for a prolonged (sub-acute) study. Hypoglycaemic effects of the 500 mg/kg dose of the extracts 
compared favourably with the positive control, glibenclamide, an oral sulfonylurea. The error bars were high in the least dose of 
250 mg/kg; this may be attributable to the varying individual responses noticed in the group. This is sometimes observed in in 
vivo biological experiments involving whole animals.  
The results obtained with the methanolic extract of H. acida portray the extract as a potential effective anti-diabetic 
agent. However, in all the experiments carried out in this study, relatively higher doses of the extract were needed to achieve an 
effect comparable to that of glibenclamide. This could likely be due to the crude nature of the extract used for the experiments. 
Following the treatment of rats with alloxan, a remarkable increase in the levels of serum total cholesterol and low density 
lipoproteins were observed. It has earlier been reported that, elevated TC and LDL-C levels in the blood of diabetics are 
considered to be a prime cause of coronary heart disease (CHD) (Gutstatin and Fuster, 1999; Genset et al., 1991; Rodrigues and 
McNeil, 1986). Many epidemiological studies showed that drug or diet induced reduction of TC and LDL-C could reduce the risk 
of CHD (Levine et al., 1995; Scott and Grundy, 1979; Kannel and McGee, 1979). In the present study, the extract of H. acida 
showed a marked decline in the TC and LDL-C levels in serum compared to the untreated control, coinciding with 
aforementioned observations. This therefore unearths the cardio-protective effect of H. acida.  
The results of this study indicate that the methanolic leaf extract of H. acida possesses significant anti-diabetic 
properties following oral administration. HA leaf extracts evidently reduced serum lipid levels associated with diabetes mellitus. 
This confirms the validity of the local use of HA leaves for the treatment of diabetes mellitus. The methanolic extract of H. acida 
leaves reduces serum lipid profile, indicating a protective role against diabetes induced hyperlipidemia. 
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